Global Laboratory Balances and Scales Market (2021 to 2028) - Proliferation of Pharmaceutical Sector in Emerging Markets Presents Opportunities - ResearchAndMarkets.com
According to this report the market is expected to reach US$ 2,131.14 million by 2028 from US$ 1,463.53 million in 2021; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The market growth is primarily attributed to rapid growth of pharmaceutical and biotechnology industry and increasing number of research pipeline of pharma-biotech companies and contract research organizations. However, the limited replacement rate among end users is likely to hamper the growth of the market to a certain extent.
Laboratory balances and scales are high performance instruments that measure accurate readings in various environments. Laboratory balances are specifically used to measure mass of the substance, while laboratory scales are utilized to measure weight of the substances. These scales and balances are classified based on weighing capacity. Weighing of materials play a vital role in research and development as well as production monitoring and quality control. Based on end user, the laboratory balances and scales market is segmented into pharmaceutical/biotechnology products testing laboratories, cosmeceutical products laboratories, academic institutes, and research laboratories. In 2020, the pharmaceutical/biotechnology products testing laboratories segment held the largest share of the market. Also, the same segment is estimated to register the highest CAGR of 6.7% during the forecast period.
The laboratory balances and scales market is witnessing substantial decline amid the COVID-19 pandemic. Certain factors such as decline in pharmaceutical production and drug discovery activities are hampering the adoption of laboratory balances and scales worldwide. However, research activities associated with the COVID-19 are expected to have marginal positive impact on the market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Laboratory Balances and Scales market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global Laboratory Balances and Scales market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Market Dynamics
Drivers
Rapid Growth of Pharmaceutical and Biotechnology Industry
Increasing Number of Research Pipeline of Pharma-Biotech Companies and Contract Research Organizations
Restraint
Limited Replacement Rate Among End Users
Opportunity
Proliferation of Pharmaceutical Sector in Emerging Markets
Future Trend
Technological Advancements in Laboratory Balances and Scales
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...
Results
For the year ended January 31, 2024, the Company's revenues decreased by $139,027,000 to $578,945,000 compared to $717,972,000 recorded for the year ended January 31, 2023, a decrease of 19.4%. This decrease is mainly explained by the...
Lendistry announces today that it has been selected to administer the Entertainment Business Interruption Fund Program (BIF) to support small Los Angeles County businesses serving the entertainment industry. This program, created and funded through...
Rocky Mountain Liquor Inc. (the "Company" or "Rocky Mountain"), listed on the TSX Venture Exchange (the "Exchange"), today reported its financial results for the full year and fourth quarter ended December 31, 2023.KEY...
Guanajuato Silver Company Ltd. (the "Company" or "GSilver") announces a brokered, best-efforts Listed Issuer Financing Exemption private placement (the "Offering") consisting of units of the Company (the "Units") at a price of C$0.20 per Unit (the...
Customers Bancorp, Inc. :
First Quarter 2024 Highlights
Q1 2024 net income available to common shareholders was $45.9 million, or $1.40 per diluted share; ROAA was 0.94% and ROCE was 12.08%.
Q1 2024 core earnings* were $46.5 million, or $1.42...